Sponsored Vasan Yegnasubramanian: How AI is transforming cancer research and treatment March 06, 2026Vol.52 No.09By John’s Hopkins Kimmel Cancer Center Communications
Sponsored Rewriting immune regulation with the CD6/CTLA‑4 CAR‑Treg platform February 20, 2026Vol.52 No.07By Christine Brown and Enrique Montero
Sponsored Antibody halts triple-negative breast cancer in preclinical models January 30, 2026Vol.52 No.04By Hayley Kamin
Sponsored Opening doors to immunotherapy in prostate cancer: A roadmap from clinic to community January 23, 2026Vol.52 No.03By Tanya Dorff
Sponsored Composite intelligence: How AI-driven biomarkers are setting the bar in immuno-oncology January 09, 2026Vol.52 No.1By Ofer Sharon, Michal Harel and Yehonatan Elon
Sponsored Mitochondrial-targeting drug attacks cancer cells from within December 19, 2025Vol.51 No.46By Hayley Kamin
Sponsored Fixing site reads without burning out the readersYunu modernizes clinical trial imaging assessment workflows December 05, 2025Vol.51 No.44By Jeff Sorenson
Sponsored Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration November 21, 2025Vol.51 No.43By The American Society of Clinical Oncology
Sponsored Advancing symptom science at City of Hope and across the globe November 14, 2025Vol.51 No.42By Jeannine M. Brant
Sponsored City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure November 07, 2025Vol.51 No.41By Ravi Salgia
